Home › Funds › AMERICAN CENTURY COMPANIES INC › ALNY

AMERICAN CENTURY COMPANIES INC position in ALNY

ALNYLAM PHARMACEUTICALS INC · Health Care

AMERICAN CENTURY COMPANIES INC reported holding 1,853,956 shares of ALNY (ALNYLAM PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$558.1M, representing 0.25% of its reported portfolio and ranking #43 among its reported holdings. AMERICAN CENTURY COMPANIES INC has disclosed ALNY holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)1.85M sh
Reported value held$558.10M
Portfolio Weight0.25%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How AMERICAN CENTURY COMPANIES INC's ALNY position evolved

AMERICAN CENTURY COMPANIES INC first disclosed a stake in ALNY in Q3 2023 at 442,743 shares (US$78.4M). The position peaked in Q3 2025 at 1,641,441 shares, worth US$748.5M. Across 12 filings, AMERICAN CENTURY COMPANIES INC increased the stake 7 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 1,853,956 shares valued at US$558.1M — an increase of 51,593 shares quarter over quarter.. Notable position changes include a 231% increase in Q1 2024 (shares rose 63% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 442.74K $78.41M New
Q4 2023 414.94K $79.42M Reduce
Q1 2024 1.37M $205.29M Add
Q2 2024 1.35M $329.06M Reduce
Q3 2024 1.59M $438.05M Add
Q4 2024 1.60M $377.44M Add
Q1 2025 1.76M $475.35M Add
Q2 2025 1.79M $584.96M Add
Q3 2025 1.64M $748.50M Reduce
Q4 2025 1.49M $590.58M Reduce
Q1 2026 1.80M $596.35M Add
Q2 2026 1.85M $558.10M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ALNY and 13F data

ALNY (ALNYLAM PHARMACEUTICALS INC) is a Health Care company. 35 other funds we track also report a position in ALNY — the largest reported positions include T. Rowe Price Investment Management, Inc. (US$1.70B), Baillie Gifford & Co (US$734.5M), Orbis Allan Gray Ltd (US$598.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ALNY

All ALNY fund holders →

FAQ

How long has AMERICAN CENTURY COMPANIES INC held ALNY?

AMERICAN CENTURY COMPANIES INC has disclosed ALNY holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is AMERICAN CENTURY COMPANIES INC's current position in ALNY?

As of Q2 2026, AMERICAN CENTURY COMPANIES INC holds 1.85M shares of ALNY (ALNYLAM PHARMACEUTICALS INC), valued at $558.10M, representing 0.25% of its reported portfolio and ranking #43.

Has AMERICAN CENTURY COMPANIES INC been buying or selling ALNY?

In the latest 13F filing (Q2 2026), AMERICAN CENTURY COMPANIES INC increased its position in ALNY. The position peaked in Q3 2025 at 1.64M shares.

Which other funds hold ALNY?

Other major institutional holders of ALNY include T. Rowe Price Investment Management, Inc., Baillie Gifford & Co, Orbis Allan Gray Ltd, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.